Home › Funds › &PARTNERS › JNJ

&PARTNERS position in JNJ

JOHNSON & JOHNSON · Health Care

&PARTNERS reported holding 809,873 shares of JNJ (JOHNSON & JOHNSON) in its Q2 2026 13F filing — a position valued at US$205.7M, representing 0.85% of its reported portfolio and ranking #18 among its reported holdings. &PARTNERS has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)809.87K sh
Reported value held$205.70M
Portfolio Weight0.85%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How &PARTNERS's JNJ position evolved

&PARTNERS first disclosed a stake in JNJ in Q3 2023 at 14,086 shares (US$2.2M). The position peaked in Q2 2026 at 809,873 shares, worth US$205.7M. Across 12 filings, &PARTNERS increased the stake 10 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 809,873 shares valued at US$205.7M — an increase of 49,143 shares quarter over quarter.. Notable position changes include a 260% increase in Q2 2024 (shares rose 11% over the following quarter), a 119% increase in Q3 2024 (shares fell 11% over the following quarter), a 68% increase in Q4 2024 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 14.09K $2.19M New
Q4 2023 21.09K $3.32M Add
Q1 2024 31.94K $5.05M Add
Q2 2024 114.99K $16.80M Add
Q3 2024 252.38K $40.85M Add
Q4 2024 425.09K $61.27M Add
Q1 2025 469.32K $76.90M Add
Q2 2025 604.76K $92.41M Add
Q3 2025 663.28K $122.98M Add
Q4 2025 763.69K $158.06M Add
Q1 2026 760.73K $185.98M Hold
Q2 2026 809.87K $205.70M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has &PARTNERS held JNJ?

&PARTNERS has disclosed JNJ holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is &PARTNERS's current position in JNJ?

As of Q2 2026, &PARTNERS holds 809.87K shares of JNJ (JOHNSON & JOHNSON), valued at $205.70M, representing 0.85% of its reported portfolio and ranking #18.

Has &PARTNERS been buying or selling JNJ?

In the latest 13F filing (Q2 2026), &PARTNERS increased its position in JNJ. The position peaked in Q2 2026 at 809.87K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.